Brief: Kairos Pharma Prices $6.2 Million Initial Public Offering
16/09/2024 19:49
Sept 16 (Reuters) - Kairos Pharma Ltd KAPA.A :
* KAIROS PHARMA PRICES $6.2 MILLION INITIAL PUBLIC OFFERING
* KAIROS PHARMA LTD - PRICES IPO OF 1.55 MILLION SHARES AT
$4.00
EACH
* KAIROS PHARMA LTD - STOCK APPROVED FOR NYSE AMERICAN
LISTING
UNDER SYMBOL 'KAPA'
* KAIROS PHARMA LTD -FOR IPO, BOUSTEAD SECURITIES LEAD
MANAGING
UNDERWRITER, EF HUTTON CO-MANAGING
Source text for Eikon: ID:nGNX6Cbm2c
Further company coverage: KAPA.A
Recent news on Kairos Pharma
See all newsBrief: Kairos Pharma Announces Signing Of Binding Strategic Asset Acquisition Of Exclusive Worldwide Rights To Cl-273 From Orbimed And Torrey Pines Investment-Backed Celyn Therapeutics
Brief: Kairos Pharma Announces Signing Of Term Sheet For Strategic Asset Acquisition
Brief: Kairos Pharma To Present Positive Safety And Efficacy Data From Phase 2 Prostate Cancer Trial At Esmo 2025
Brief: Kairos Pharma Reports Positive Interim Phase 2 Data For ENV105 In Advanced Prostate Cancer, PFS Over One Year
Brief: Kairos Pharma Announces Virtual KOL Event To Provide Perspectives On ENV105 Interim Efficacy Results In Advanced Prostate Cancer